- Tytuł:
- Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study
- Autorzy:
- Źródło:
- In The Lancet Regional Health - Americas March 2024 31
Czasopismo naukowe